Pfam Domains GO Terms
| Fork head |
| metanephric capsule development |
| renal capsule morphogenesis |
| metanephric capsule morphogenesis |
| metanephric capsule specification |
| renal capsule development |
| metanephric capsule formation |
| renal capsule specification |
| renal capsule formation |
| dichotomous subdivision of terminal units involved in ureteric bud branching |
| nephrogenic mesenchyme development |
| luteinizing hormone secretion |
| gonadotropin secretion |
| pattern specification involved in metanephros development |
| renal system pattern specification |
| pattern specification involved in kidney development |
| dichotomous subdivision of an epithelial terminal unit |
| endocrine hormone secretion |
| kidney mesenchyme development |
| DNA binding, bending |
| metanephric nephron development |
| positive regulation of BMP signaling pathway |
| positive regulation of kidney development |
| branching involved in ureteric bud morphogenesis |
| endocrine process |
| ureteric bud morphogenesis |
| mesonephric tubule morphogenesis |
| regulation of kidney development |
| nephron tubule morphogenesis |
| nephron epithelium morphogenesis |
| nephron morphogenesis |
| renal tubule morphogenesis |
| hormone secretion |
| nephron tubule development |
| renal tubule development |
| hormone transport |
| metanephros development |
| kidney morphogenesis |
| ureteric bud development |
| mesonephric tubule development |
| mesonephric epithelium development |
| regulation of BMP signaling pathway |
| mesonephros development |
| nephron epithelium development |
| positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| nephron development |
| kidney epithelium development |
| branching morphogenesis of an epithelial tube |
| morphogenesis of a branching epithelium |
| morphogenesis of a branching structure |
| signal release |
| mesenchyme development |
| connective tissue development |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| axon guidance |
| neuron projection guidance |
| kidney development |
| regulation of cellular response to growth factor stimulus |
| renal system development |
| epithelial tube morphogenesis |
| urogenital system development |
| regionalization |
| axonogenesis |
| axon development |
| sequence-specific DNA binding |
| morphogenesis of an epithelium |
| cell morphogenesis involved in neuron differentiation |
| pattern specification process |
| DNA-binding transcription activator activity, RNA polymerase II-specific |
| neuron projection morphogenesis |
| plasma membrane bounded cell projection morphogenesis |
| cell projection morphogenesis |
| RNA polymerase II proximal promoter sequence-specific DNA binding |
| cell part morphogenesis |
| regulation of hormone levels |
| chemotaxis |
| taxis |
| cell morphogenesis involved in differentiation |
| tissue morphogenesis |
| tube morphogenesis |
| neuron projection development |
| DNA-binding transcription factor activity |
| cell morphogenesis |
| neuron development |
| cellular component morphogenesis |
| tube development |
| anatomical structure formation involved in morphogenesis |
| animal organ morphogenesis |
| secretion by cell |
| neuron differentiation |
| export from cell |
| epithelium development |
| cell-cell signaling |
| secretion |
| plasma membrane bounded cell projection organization |
| cell projection organization |
| negative regulation of transcription, DNA-templated |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| locomotion |
| negative regulation of RNA metabolic process |
| positive regulation of developmental process |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| DNA binding |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| generation of neurons |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| movement of cell or subcellular component |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| neurogenesis |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cell development |
| positive regulation of signal transduction |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| tissue development |
| positive regulation of cell communication |
| positive regulation of signaling |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| system process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| 5-Fluorouracil 20μM R00 exp2 | -2.24 |
| GSK591 2.6μM R03 exp128 | -1.91 |
| WYE-354 6μM R02 exp90 | 1.84 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|
Expression Distribution